Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs74129718 | chr10:29845415 | G/T | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs74129721 | chr10:29847287 | A/C | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs74129723 | chr10:29850135 | G/A | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs74129724 | chr10:29850238 | A/G | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs74129725 | chr10:29850701 | C/T | 4.8E-11 | 177 | 25.53 | 18.7 | 10.3 | KM Plot |
PCPG | rs74203691 | chr16:71749267 | G/C | 9.25E-6 | 175 | 23.83 | 32.03 | 14.5 | KM Plot |
PCPG | rs7420836 | chr2:242583553 | G/A | 9.01E-11 | 173 | 25.67 | 25 | 10.3 | KM Plot |
PCPG | rs742312 | chr16:1719774 | G/A | 0 | 178 | 25.28 | 27.27 | 2.93 | KM Plot |
PCPG | rs7424502 | chr2:242583153 | C/T | 9.01E-11 | 173 | 25.67 | 25 | 10.3 | KM Plot |
PCPG | rs74246245 | chr16:56457270 | C/T | 0.000204 | 177 | 25.17 | 26.97 | 36.37 | KM Plot |
PCPG | rs74251568 | chr16:89903416 | A/C | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs74251570 | chr16:89910068 | C/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs74267002 | chr3:80451005 | TAAGCAAGC/T | 0.000182 | 171 | 25.4 | 25.92 | 22.52 | KM Plot |
PCPG | rs74311713 | chr16:56465661 | G/GTA | 0.000227 | 175 | 25.08 | 34.37 | 36.37 | KM Plot |
PCPG | rs7431461 | chr3:80599812 | C/T | 0.000372 | 178 | 27.6 | 23.53 | 19.53 | KM Plot |